Optimization of 5-phenyl-3-pyridinecarbonitriles as PKCtheta inhibitors.

Bioorg Med Chem Lett

Wyeth Research, Chemical Sciences, 401 N. Middletown Road, Pearl River, NY 10965, United States.

Published: July 2009

The key intermediate, 4-chloro-5-iodo-3-pyridinecarbonitrile, allowed for ready optimization of the PKCtheta inhibitory activity of a series of 3-pyridinecarbonitriles. Analog 13b with a 4-methylindol-5-ylamino group at C-4 and a 4-(2-(4-methylpiperazin-1-yl)ethoxy)phenyl group at C-5 had an IC(50) value of 7.4nM for the inhibition of PKCtheta.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2009.04.126DOI Listing

Publication Analysis

Top Keywords

optimization 5-phenyl-3-pyridinecarbonitriles
4
5-phenyl-3-pyridinecarbonitriles pkctheta
4
pkctheta inhibitors
4
inhibitors key
4
key intermediate
4
intermediate 4-chloro-5-iodo-3-pyridinecarbonitrile
4
4-chloro-5-iodo-3-pyridinecarbonitrile allowed
4
allowed ready
4
ready optimization
4
optimization pkctheta
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!